HDGFL2 and Miyoshi myopathy: In this study, we applied a CRISPR/Cas9 sgRNA screen system and identified genes responsible for sensitivity to bortezomib in a bone marrow–bearing MM growth model of NOD/SCID (NSG) mice and identified HRP2 as a suppressor of chemoresistance to PIs.